Download Citation
Article Source:
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
Nagata E,
Ogino M,
Iwamoto K,
Kitagawa Y,
Iwasaki Y,
et al.
(2016)
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients.
PLOS ONE 11(2): e0149509.
https://doi.org/10.1371/journal.pone.0149509